DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Chen C-N, Lin CP, Huang K-K. et al.
Inhibition of SARS-CoV 3C-like protease activity by
theaflavin-3,3'-digallate’ (TF3).
Evid Based Complement Alternat Med 2005;
2: 209-215
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.